GlassScriptPhysician profile
Luis Antonio Ramos
NPI 1699076000
$1,296.35
in general payments reported to CMS, 2019-2025
20 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.86 · 2021: $28.25 · 2022: $282 · 2023: $302 · 2024: $308 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $463.93 | 2021-2025 | Puraply, Apligraf |
| Smith+Nephew, INC. | $245.99 | 2022-2025 | Collagenase Santyl, Renasys Touch, Regranex |
| Mimedx Group, INC. | $99.71 | 2024-2025 | |
| Hydrofera LLC | $52.06 | 2023-2024 | Hydrofera Blue Ready - Border, Hydrofera Blue |
| Convatec INC. | $44.36 | 2025 | |
| Surgenex LLC | $44.28 | 2025 | Surmatrix, Pellograft, Renograft |
| Kerecis Limited | $41.05 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Solventum Corporation | $37.31 | 2024 | Activ.A.C. |
| Pfizer INC. | $34.37 | 2025 | |
| Bioventus LLC | $32.69 | 2022 | |
| Alexion Pharmaceuticals, INC. | $29.73 | 2025 | Strensiq |
| Molnlycke Health Care US, LLC | $28.64 | 2022-2024 | Mepilex Ag, Mepilex, Mepilex Transfer Ag |
| Medline Industries LP | $26.86 | 2023 | |
| Kci USA, INC. | $22.96 | 2023 | Activ.A.C., 3m Coban |
| Reapplix INC. | $20.11 | 2025 | 3c Patch Kit - Box |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $16.86 | 2020 | |
| Hartmann USA, INC. | $15.43 | 2022 | |
| Evoke Pharma, INC. | $14.14 | 2023 | Gimoti |
| Almatica Pharma LLC | $13.87 | 2023 | Loreev Xr |
| Triad Life Sciences INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Ramos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.